Literature DB >> 6239061

Kinetic properties of erythrocyte phosphofructokinase in patients with type VII glycogenosis from two families--close similarity to liver type phosphofructokinase.

T Shimizu, N Kono, I Mineo, S Sumi, K Nonaka, S Tarui, W Koyama.   

Abstract

The kinetic properties of phosphofructokinases (PFKs) from normal human liver, muscle and erythrocytes, and from erythrocytes of two unrelated patients with type VII glycogenosis (muscle PFK deficiency, McKusick 23280) were analysed in this study. Sensitivity to inhibition by ATP and to inhibition by 3-phosphoglycerate, 2-phosphoglycerate, phosphoenolpyruvate and citrate were quite different for muscle and liver PFKs. The kinetic characteristics of normal erythrocyte PFK were intermediate between those of muscle and liver PFKs. The kinetic constants of erythrocyte PFK of a patient in one family were indistinguishable from those in the other family. In addition, kinetic behaviour of residual PFK activity in erythrocytes from patients in the two families were quite similar to those of normal liver PFK. These results of kinetic analyses provide convincing evidence for the concept that normal erythrocyte PFK consists of muscle and liver type subunits. Residual erythrocyte PFK activity in type VII glycogenosis is thus concluded to reflect the activity of liver type PFK existing in patient's erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239061     DOI: 10.1007/bf01801765

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  16 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

Review 2.  Phosphofructokinase.

Authors:  K Uyeda
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1979

3.  Glucose- and mannose-1,6-P2 as activators of phosphofructokinase in red blood cells.

Authors:  I A Rose; J V Warms
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

4.  Chicken liver phosphofructokinase. I. Crystallization and physicochemical properties.

Authors:  N Kono; K Uyeda; R M Oliver
Journal:  J Biol Chem       Date:  1973-12-25       Impact factor: 5.157

5.  Purification and properties of rabbit erythrocyte phosphofructokinase.

Authors:  S Tarui; N Kono; K Uyeda
Journal:  J Biol Chem       Date:  1972-02-25       Impact factor: 5.157

6.  Phosphofructokinase (PFK) deficiency due to a catalytically inactive mutant M-type subunit.

Authors:  A Zenella; M Mariani; G Meola; F Fagnani; G Sirchia
Journal:  Am J Hematol       Date:  1982-05       Impact factor: 10.047

7.  Fructose 2,6-bisphosphate 2 years after its discovery.

Authors:  H G Hers; E Van Schaftingen
Journal:  Biochem J       Date:  1982-07-15       Impact factor: 3.857

8.  Isoenzymes of human phosphofructokinase.

Authors:  J F Koster; R G Slee; T J Van Berkel
Journal:  Clin Chim Acta       Date:  1980-04-25       Impact factor: 3.786

9.  Alteration of glycolytic intermediary metabolism in erythrocytes during diabetic ketoacidosis and its recovery phase.

Authors:  N Kono; M Kuwajima; S Tarui
Journal:  Diabetes       Date:  1981-04       Impact factor: 9.461

10.  The effect of natural and synthetic D-fructose 2,6-bisphosphate on the regulatory kinetic properties of liver and muscle phosphofructokinases.

Authors:  K Uyeda; E Furuya; L J Luby
Journal:  J Biol Chem       Date:  1981-08-25       Impact factor: 5.157

View more
  1 in total

1.  Characterization of phosphofructokinase-deficient canine erythrocytes.

Authors:  J W Harvey; M G Pate; Y Mhaskar; G A Dunaway
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.